Biofrontera AG Sponsored ADR Repayment/Issuance of Debt (Net)

Repayment/Issuance of Debt (Net) of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Repayment/Issuance of Debt (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Repayment/Issuance of Debt (Net) for the quarter ending June 30, 2021 was $-805 Thousand (a -1.75% decrease compared to previous quarter)
  • Year-over-year quarterly Repayment/Issuance of Debt (Net) decreased by -83.93%
  • Annual Repayment/Issuance of Debt (Net) for 2021 was $-18.5 Million (a -0.18% decrease from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2021 was $-18.5 Million (a 1089.37% increase from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2020 was $-1.56 Million (a -136.42% decrease from previous year)
  • Twelve month Repayment/Issuance of Debt (Net) ending June 30, 2021 was $-1.01 Million (a -120.19% decrease compared to previous quarter)
  • Twelve month trailing Repayment/Issuance of Debt (Net) decreased by -107.5% year-over-year
Trailing Repayment/Issuance of Debt (Net) for the last four month:
30 Jun '21 30 Jun '20 31 Dec '19 30 Sep '19
$-1.01 Million $5.03 Million $5.79 Million $13.5 Million
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Repayment/Issuance of Debt (Net) of Biofrontera AG Sponsored ADR

Most recent Repayment/Issuance of Debt (Net)of BFAGY including historical data for past 10 years.

Interactive Chart of Repayment/Issuance of Debt (Net) of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-0.8 $-18.48
2020 $-0.82 $-1.56
2019 $5.62 $-5.01 $5.24 $4.28
2018 $-0.06 $-0.06
2017 $13.35 $5.25 $12.84
2016 $-4.11 $-1.63

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic